Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • Equity, Diversity, and Inclusion
    • Innovations in Care Delivery
    • Without Borders
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • Equity, Diversity, and Inclusion
    • Innovations in Care Delivery
    • Without Borders
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Articles
  • Issues

User menu

  • My Alerts
  • Log in

Search

  • Advanced search
Neurology Genetics
Home
A peer-reviewed clinical and translational neurology open access journal
  • My Alerts
  • Log in
Site Logo
  • Home
  • Articles
  • Issues

Share

February 2020; 6 (1) ArticleOpen Access

Cerebral small vessel disease due to a unique heterozygous HTRA1 mutation in an African man

Olusegun John Oluwole, Heba Ibrahim, Debora Garozzo, Karim Ben Hamouda, Saly Ismail Mostafa Hassan, Ahmed Metwaly Hegazy, Abdul Karim Msaddi
First published December 26, 2019, DOI: https://doi.org/10.1212/NXG.0000000000000382
Olusegun John Oluwole
From the Department of Neurology (O.J.O., A.M.H.) and Department of Radiology (H.I.), Neuro Spinal Hospital Dubai; Ain Shams University (H.I.), Cairo, Egypt; Department of Neurosurgery (D.G., K.B.H., A.K.M.) and Department of Clinical Pathology (S.I.M.H.), Neuro Spinal Hospital Dubai, United Arab Emirates; and Beni-Suef University (S.I.M.H.), Egypt.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heba Ibrahim
From the Department of Neurology (O.J.O., A.M.H.) and Department of Radiology (H.I.), Neuro Spinal Hospital Dubai; Ain Shams University (H.I.), Cairo, Egypt; Department of Neurosurgery (D.G., K.B.H., A.K.M.) and Department of Clinical Pathology (S.I.M.H.), Neuro Spinal Hospital Dubai, United Arab Emirates; and Beni-Suef University (S.I.M.H.), Egypt.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Debora Garozzo
From the Department of Neurology (O.J.O., A.M.H.) and Department of Radiology (H.I.), Neuro Spinal Hospital Dubai; Ain Shams University (H.I.), Cairo, Egypt; Department of Neurosurgery (D.G., K.B.H., A.K.M.) and Department of Clinical Pathology (S.I.M.H.), Neuro Spinal Hospital Dubai, United Arab Emirates; and Beni-Suef University (S.I.M.H.), Egypt.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karim Ben Hamouda
From the Department of Neurology (O.J.O., A.M.H.) and Department of Radiology (H.I.), Neuro Spinal Hospital Dubai; Ain Shams University (H.I.), Cairo, Egypt; Department of Neurosurgery (D.G., K.B.H., A.K.M.) and Department of Clinical Pathology (S.I.M.H.), Neuro Spinal Hospital Dubai, United Arab Emirates; and Beni-Suef University (S.I.M.H.), Egypt.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Saly Ismail Mostafa Hassan
From the Department of Neurology (O.J.O., A.M.H.) and Department of Radiology (H.I.), Neuro Spinal Hospital Dubai; Ain Shams University (H.I.), Cairo, Egypt; Department of Neurosurgery (D.G., K.B.H., A.K.M.) and Department of Clinical Pathology (S.I.M.H.), Neuro Spinal Hospital Dubai, United Arab Emirates; and Beni-Suef University (S.I.M.H.), Egypt.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ahmed Metwaly Hegazy
From the Department of Neurology (O.J.O., A.M.H.) and Department of Radiology (H.I.), Neuro Spinal Hospital Dubai; Ain Shams University (H.I.), Cairo, Egypt; Department of Neurosurgery (D.G., K.B.H., A.K.M.) and Department of Clinical Pathology (S.I.M.H.), Neuro Spinal Hospital Dubai, United Arab Emirates; and Beni-Suef University (S.I.M.H.), Egypt.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abdul Karim Msaddi
From the Department of Neurology (O.J.O., A.M.H.) and Department of Radiology (H.I.), Neuro Spinal Hospital Dubai; Ain Shams University (H.I.), Cairo, Egypt; Department of Neurosurgery (D.G., K.B.H., A.K.M.) and Department of Clinical Pathology (S.I.M.H.), Neuro Spinal Hospital Dubai, United Arab Emirates; and Beni-Suef University (S.I.M.H.), Egypt.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Cerebral small vessel disease due to a unique heterozygous HTRA1 mutation in an African man
Olusegun John Oluwole, Heba Ibrahim, Debora Garozzo, Karim Ben Hamouda, Saly Ismail Mostafa Hassan, Ahmed Metwaly Hegazy, Abdul Karim Msaddi
Neurol Genet Feb 2020, 6 (1) e382; DOI: 10.1212/NXG.0000000000000382

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
244

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Abstract

Objective To describe the case of an African patient who was diagnosed with cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL).

Methods Case report and literature review.

Results We present a 39-year-old Gabonese man who developed progressive gait difficulty at the age of 32, followed by insidious tetraparesis, urinary sphincter disturbance, spastic dysarthria, cognitive dysfunction, and seizures. Brain imaging was performed many years after disease onset and revealed diffuse confluent white matter lesions and lacunar infarcts. He tested negative for acquired white matter disease, but genetic screening detected a genetic variant of HTRA1 gene (G283R), which has not been previously reported.

Conclusions CARASIL is a disease that usually affects Asian patients. This case report describes a unique case of an African patient diagnosed with CARASIL and a novel genetic mutation in HTRA1 that has not been previously described in the literature.

Glossary

CARASIL=
Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy

Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL) is a familial autosomal recessive vascular disorder characterized by nonhypertensive cerebral small vessel disease with early adulthood onset of subcortical infarcts, progressive motor and cognitive impairment, alopecia, and spondylosis.1 It is a single-gene disorder that directly affects the cerebral small blood vessels. The disease is caused by mutation in the HTRA1 gene on chromosome 10q, which encodes a serine protease (HTRA1) that normally represses the expression of transforming growth factor (TGF)-β family.2

CARASIL is a rare disease, with less than 70 cases published in the literature thus far.3,4 Most of the reported cases are from Asia, with only few cases described in Europe.4,–,7 There are still no known reports from Africa.

Methods

We present a case of CARASIL in an African patient affected by a unique HTRA1 mutation.

Standard protocol approvals, registrations, and patient consents

The study was preapproved by the Research and Ethics Committee of the Neuro Spinal Hospital, Dubai, and written informed consent was obtained from the patient's wife because the patient was not in a position to do so because of cognitive impairment. The written consent also gave authorization to disclose any potentially recognizable information in the report.

Data availability

The authors confirm that all data supporting the findings of this study are available within the article.

Case report

A 39-year-old man from Gabon in Central Africa was referred to our hospital with a 7-year history of slowly progressive bilateral lower limb weakness and gradual gait deterioration. Earlier spine imaging in his home country had revealed a small thoracic syrinx (figure 1), and he had undergone thoracic laminectomy at T3 and T4 levels based on the assumption that his symptoms were related to the syrinx. He had continued to deteriorate despite the surgical intervention and had developed weakness in the upper limbs eventually. Further investigation 1 year later had revealed cervical disc herniation, and he had subsequently undergone cervical disc surgery, which also had not improved his symptoms. In the year before presentation, he had developed cognitive symptoms in addition to progressive dysarthria, urinary incontinence, and epileptic seizures. Both of his parents were Gabonese, and he had 2 siblings, none of whom had any history of neurologic disease at the time of this writing. His 11-year-old daughter is also free of neurologic disease.

Figure 1
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1 Patient's dorsal spine MRI showing cord findings and previous intervention

(A) Sagittal T2WI of the dorsal spine showing the site of the previous surgery (curved arrow) and intramedullary syrinx of the upper thoracic cord (arrows). (B) Sagittal and (C and D) axial T2WI of the thoracic spine showing cord affection by intramedullary patch of hyper intensity (arrows).

On examination, he showed cognitive impairment in the form of deficient attention span, slow mentation, apathy, poor episodic memory and difficulty following verbal instructions. Pupillary examination and fundoscopy were unremarkable. He had spastic dysarthria and spastic tetraparesis, with power of grade 2 of 5 in the lower limbs and grade 4 of 5 in the upper limbs. He was using a wheelchair and had suspended sensory deficit to pinprick from the umbilicus to the shoulders bilaterally. He was on urinary catheter because of urinary incontinence.

Brain MRI performed at our hospital showed confluent, symmetric hyperintense lesions in the periventricular and deep white matter as well as lacunar infarcts, with relative sparing of the U-fibers (figure 2). His dorsal spine MRI showed a linear central intramedullary hyperintensity representing a small syrinx (figure 1). In the differential diagnosis, we excluded the common acquired causes of white matter disease, including sporadic vascular diseases, vasculitis, MS, and other immunologic and neuroinflammatory disorders. Notably, vasculitis screening, CSF oligoclonal bands, antiaquaporin 4 antibody, antimyelin oligodendrocyte antibody, serum and CSF angiotensin converting enzyme assay, CSF venereal disease research laboratory test, and HIV test were all negative. The patient also did not have any of the known traditional vascular risk factors such as hypertension and diabetes mellitus.

Figure 2
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2 Patient's brain MRI showing hemispheric and brainstem findings

Pattern of periventricular white matter involvement in different pulse sequences in axial FLAIR (A and B), note lacunar infarcts (arrow head) is seen in B. (C) Coronal T2WI and (D) Axial T2WI showing affection of the right aspect of pons (arrows) creeping to the middle cerebral peduncle. FLAIR = fluid-attenuated inversion recovery.

Genetic testing for an expanded panel of genes associated with leukodystrophies and other white matter diseases was carried out and showed a heterozygous mutation in the HTRA1 gene, HTRA1 G283R, in which glycine was replaced by arginine at position 283 in the amino acid sequence of the HTRA1 protein (Gly283Arg) because of a missense mutation in which adenine was substituted for guanine at codon 847 (GGA > AGA). We could not carry out genetic screening on his parents because his father had died at the time of his presentation. We were thus unable to determine if this mutation was inherited or arose de novo. He continued to deteriorate cognitively and suffered further seizures until his death in April 2019, 8 years after disease onset.

Discussion

CARASIL is a rare genetic vascular disorder which has been linked to a single-gene mutation involving HTRA1.2 This gene was determined in 20092 and is believed to encode a serine protease (HTRA1) that represses the expression of TGF-β family.2 The resultant effect of this mutation is an increased expression of the TGF-β family within the tunica intima and media of cerebral small vessels, which ultimately leads to arteriolosclerosis.2

The disorder is inherited in an autosomal recessive manner, and heterozygotes are not expected to manifest disease. Nevertheless, symptomatic heterozygote carriers have been reported.8,9 This category of patients has less frequent non-neurological features such as alopecia.8,9 Likewise, our patient had no alopecia, thus showing some similarities to the reported heterozygous cases.

The radiologic hallmarks of CARASIL include high-signal-intensity lesions in the periventricular white matter and deep white matter as well as multiple lacunar infarctions in the basal ganglia and thalamus, with a relative sparing of the superficial white matter (U-fibers).10 Many of these features were found in our patient. The diffuse white matter lesions may also extend to the temporal poles or external capsules,10 although no temporal pole lesions were found in our case (figure 2).

About 48 cases of this disorder have been published from Japan and China, slightly more than a dozen cases from Europe and, more recently, 8 cases from Turkey.4,–,7 Up to the time of writing this report, occurrence of this disease is yet to be reported in Africans.

Hitherto, to our knowledge, the G283R variant has neither been documented as a pathogenic variant nor has it been reported as a benign variant. However, we surmise that this variant is pathogenic, considering that a heterozygous missense substitution at the same position (G283E) has been reported in an individual with cerebral small vessel disease, cognitive impairment, and gait disturbance.9 In that publication, functional analysis suggested that the mutant gene might cause disease through defective trimerization with the wild type.9 Although functional analysis was not performed in our case, we suppose that G283R may possibly have similar molecular characteristics as G283E and may have similar pathogenicity.

Our case presents unique peculiarities in comparison with similar cases described in the literature. First, this disease is yet to be reported in Africans. Second, we report a genetic variant of HTRA1 gene mutation that has not been previously reported in the literature (G283R), and finally, we add to the few reported cases of symptomatic heterozygote forms of HTRA1 mutation.

Author contributions

O.J. Oluwole was involved in study conceptualization, data acquisition and interpretation, manuscript writing, final editing, and manuscript submission. H. Ibrahim was involved in data acquisition and interpretation, manuscript writing, and final editing. D. Garrozo was involved in manuscript writing and final editing. K Ben Hamouda was involved in final editing of the scientific content. S.I Mostafa Hassan was involved in data acquisition and final editing. A.M. Hegazy was involved in final editing of the scientific content. A.K. Msaddi was involved in the final editing of the scientific content.

Study funding

Genetic testing was funded out of pocket by the authors.

Disclosure

Disclosures available: Neurology.org/NG.

Footnotes

  • Go to Neurology.org/NG for full disclosures. Funding information is provided at the end of the article.

  • The Article Processing Charge was funded by the authors.

  • Received March 28, 2019.
  • Accepted in final form October 15, 2019.
  • Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

References

  1. 1.↵
    1. Yanagawa S,
    2. Ito N,
    3. Arima K,
    4. Ikeda S
    . Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy. Neurology 2002;58:817–820.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Hara K,
    2. Shiga A,
    3. Fukutake T, et al
    . Association of HTRA1 mutations and familial ischemic cerebral small-vessel disease. N Engl J Med 2009;360:1729–1739.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Wang XL,
    2. Li CF,
    3. Guo HW,
    4. Cao BZ
    . A novel mutation in the HTRA1 gene identified in Chinese CARASIL pedigree. CNS Neurosci Ther 2012;18:867–869.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Chen Y,
    2. He Z,
    3. Meng S,
    4. Li L,
    5. Yang H,
    6. Zhang X
    . A novel mutation of the high-temperature requirement A serine peptidase 1 (HTRA1) gene in a Chinese family with cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL). J Int Med Res 2013;41:1445–1455.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Cordeiro IM,
    2. Nzwalo H,
    3. Sá F, et al
    . Shifting the CARASIL paradigm report of a non-Asian family and literature review. Stroke 2015;46:1110–1112.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Bianchi S,
    2. Di Palma C,
    3. Gallus GN, et al
    . Two novel HTRA1 mutations in a European CARASIL patient. Neurology 2014;82:898–900.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Bayrakli F,
    2. Balaban H,
    3. Gurelik M,
    4. Hizmetli S,
    5. Topaktas S
    . Mutation in the HTRA1 gene in a patient with degenerated spine as a component of CARASIL syndrome. Turk Neurosurg 2014;24:67–69.
    OpenUrlPubMed
  8. 8.↵
    1. Verdura E,
    2. Hervé D,
    3. Scharrer E, et al
    . Heterozygous HTRA1 mutations are associated with autosomal dominant cerebral small vessel disease. Brain 2015;138:2347–2358.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Nozaki H,
    2. Kato T,
    3. Nihonmatsu M, et al
    . Distinct molecular mechanisms of HTRA1 mutants in manifesting heterozygotes with CARASIL. Neurology 2016;86:1964–1974.
    OpenUrlCrossRef
  10. 10.↵
    1. Fukutake T,
    2. Shimoe Y,
    3. Hattori T
    . Differences in MRI lesion patterns of two hereditary vascular leukoencephalopathy: CADASIL and CARASIL. J Stroke Cerebrovasc Dis 2000;9(suppl 1):263–264.
    OpenUrl
View Abstract

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All contributors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.ng.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Letters

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Letters Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Glossary
    • Methods
    • Case report
    • Discussion
    • Author contributions
    • Study funding
    • Disclosure
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures

Related Articles

  • No related articles found.

Topics Discussed

  • All Genetics
  • Stroke in young adults

Alert Me

  • Alert me when eletters are published
Advertisement
Neurology Genetics: 7 (1)

Articles

  • Articles
  • Issues
  • Popular Articles

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology: Genetics | Online ISSN: 2376-7839

© 2021 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise